NR2F6 promotes the malignant progression of neuroblastoma as an indicator of poor prognosis.
<h4>Background</h4>NR2F6 is an orphan nuclear receptor with dual tumorigenic activity in the immune system and tumor cells, playing an essential role in tumor differentiation and immunity. This study aimed to investigate the expression level of NR2F6 in various tumors and its effect on n...
Saved in:
| Main Authors: | Yimeng Liu, Zhaoxia Zhang, Tao Mi, Liming Jin, Zhaoying Wang, Mujie Li, Jinkui Wang, Xin Wu, Junyi Luo, Jiayan Liu, Chunnian Ren, Dawei He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0324334 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human Mesenchymal Stem Cells-Derived Exosome Mimetic Vesicles Regulation of the MAPK Pathway and ROS Levels Inhibits Glucocorticoid-Induced Apoptosis in Osteoblasts
by: Hongxu Lu, et al.
Published: (2023-01-01) -
Olfactory neuroblastoma: a rare sinonasal malignancy
by: Athar Adnan Uppal, et al.
Published: (2024-06-01) -
Circulating tumor cells and clusters as liquid biomarkers for the diagnosis and prognosis of neuroblastoma
by: Huanli Xu, et al.
Published: (2025-07-01) -
c-Jun promotes neuroblastoma cell differentiation by inhibiting APC formation via CDC16 and reduces neuroblastoma malignancy
by: Yunyun Wang, et al.
Published: (2025-03-01) -
Predictive role of SLC1A5 in neuroblastoma prognosis and immunotherapy
by: Jian Cheng, et al.
Published: (2025-01-01)